2
Clinical Trials associated with Cellgram-LC / RecruitingNot Applicable Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study
This Long-term follow-up is designed to evaluate the safety of patient with Alcoholic Liver Cirrhosis who had administered Cellgram-LC in PMC-P-07 study.
A Multicenter, Randomized, Open-label Phase III Clinical Trial to Evaluate Efficacy and Safety of the Cellgram-LC in Patients With Alcoholic Liver Cirrhosis
This phase III clinical trial is designed to evaluate the efficacy and safety of autologous Mesenchymal Stem Cells (MSC) injected hepatic artery.
100 Clinical Results associated with Cellgram-LC
100 Translational Medicine associated with Cellgram-LC
100 Patents (Medical) associated with Cellgram-LC
100 Deals associated with Cellgram-LC